SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Preventive Visit — Flannery O'Connor — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFlannery O'Connor
Date of birth1925-03-25
IdentifiersMRN HR-ML046-SYN-TD; SSN (made up) 000-46-1853
Document date1950-10-05
AuthorAugusta Pemberton-Diallo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Adult preventive visit; no new complaints. [S]

History of Present Illness

Ms. O'Connor returns for her yearly preventive visit, five months into treatment for lupus nephritis. Her joints and skin are quiet, and the three-month results showed the urine protein falling by half. She is on prednisone 7.5 mg a day, tapering. The bladder infection in June cleared with nitrofurantoin. She writes five mornings a week and has finished a draft of her novel. She completed the health risk assessment before the visit. [S]

ElementDetail
VisitAdult preventive visit, age 25
Active conditionsSystemic lupus erythematosus with class III lupus nephritis on treatment
MedicinesMycophenolate 1000 mg twice daily; belimumab 200 mg weekly; hydroxychloroquine 300 mg daily; losartan 25 mg daily; prednisone 7.5 mg daily, tapering; vitamin D3 1000 units daily
Recent eventsCystitis in June, resolved
Functional statusIndependent; no morning stiffness

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, and much better than in the spring
PsychosocialSupported by friends and her writing community; feels safe; health insurance covers her medicines
BehavioralNever smoker; alcohol rarely; walks most days; sunscreen and a hat outdoors
Activities of daily livingIndependent in all
Instrumental activities of daily livingManages her medicines, injections, money, and correspondence
Sexual and reproductive healthOne long-term partner; intrauterine system in place; not planning pregnancy this year
Home safetySmoke detectors working; wears a seat belt; gloves and a mask when cleaning the bird pens
Hearing and visionBaseline eye examination for hydroxychloroquine in June normal; hearing normal
SleepEight hours; less fatigue

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever; weight stable after a small gain on prednisone
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeNo mouth ulcers
CardiovascularNegativeNo chest pain or leg swelling
RespiratoryNegativeNo cough or pleuritic pain
GastrointestinalNegativeNo diarrhea or abdominal pain on mycophenolate
GenitourinaryNegativeNo urinary symptoms; light periods with the intrauterine system
MusculoskeletalNegativeNo joint pain; no hip, groin, or knee pain
IntegumentaryNegativeNo rash; hair regrowing
NeurologicalNegativeNo headaches or seizures
PsychiatricNegativeMood good; PHQ-2 score 0

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for joint pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route1950-04-13activeS
Hydroxychloroquine sulfate 300 mg oral tablet, one tablet by mouth once daily (5 mg/kg of actual body weight), long termOne tablet once dailyOral route1950-04-22activeS
Losartan potassium 25 mg oral tablet, one tablet by mouth once daily, for proteinuria and blood pressureOne tablet once dailyOral route1950-04-22activeS
Methylprednisolone 500 mg intravenous infusion once daily for three daysOne infusion daily for three daysIntravenous route1950-04-29 to 1950-05-01completedS
Prednisone 5 mg oral tablet: 30 mg (six tablets) once daily from the day after the last pulse, reduced by 5 mg every two weeks to 10 mg, then to 5 mg a day or less by six monthsOnce daily, taperingOral route1950-04-29activeS
Mycophenolate mofetil 500 mg oral tablet, one tablet twice daily for one week, then two tablets (1000 mg) twice dailyTwo tablets twice dailyOral route1950-04-29activeS
Belimumab 200 mg/mL subcutaneous autoinjector: 400 mg (two injections) once weekly for four doses, then 200 mg once weeklyOnce weekly by self-injectionSubcutaneous route1950-04-29activeS
Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route1950-04-29activeS
Nitrofurantoin (monohydrate/macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for seven daysOne capsule twice daily for seven daysOral route1950-06-15 to 1950-06-21completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1950-10-05Body height168cmS
1950-10-05Body weight62.2kgS
1950-10-05Body mass index (BMI) [Ratio]22kg/m2S
1950-10-05Systolic blood pressure116mm[Hg]S
1950-10-05Diastolic blood pressure74mm[Hg]S
1950-10-05Heart rate70/minS
1950-10-05Respiratory rate14/minS
1950-10-05Body temperature36.6CelS
1950-10-05Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1950-10-05Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1950-10-05Total score [AUDIT-C]1{score}S

Physical Exam

Vital signs recorded on 1950-10-05; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell-appearing; BMI 22.0
EyesPupils equal and reactive
MouthNo ulcers; teeth in good repair
NeckNo nodes
CardiovascularRegular rhythm; no murmur or rub; no edema
RespiratoryClear
MusculoskeletalNo synovitis; full, painless hip movement
SkinNo malar or discoid rash; no suspicious moles
PsychiatricEngaged and funny

Problems

ProblemClinical statusVerificationCodeProvenance
Pain and swelling of the small joints of both hands, the wrists, and the knees for three months, with an hour of morning stiffness, evening fevers to 38 °C, fatigue, and a red rash over the cheeks and nose after sun; told elsewhere it might be rheumatoid arthritis; cause to be establishedresolvedconfirmed M25.50S — Synthetic presenting concern at the index visit, superseded by the diagnosis of systemic lupus erythematosus at the second visit; joint pain in 1950 with suspected rheumatoid arthritis is documented (D).
Protein and blood in the urine: protein-to-creatinine ratio 1.6 g/g and 18 red cells per high-power field, with normal creatinine; cause to be establishedresolvedconfirmed R80.9S — Synthetic presenting finding at the index visit, superseded by the kidney biopsy diagnosis at the third visit.
Systemic lupus erythematosus, classified by the EULAR/ACR criteria (ANA 1:640 homogeneous; score 32 before the biopsy): inflammatory arthritis, acute cutaneous lupus (malar rash), fever, leukopenia with lymphopenia, mild thrombocytopenia, low C3 and C4, anti-dsDNA and anti-Sm positive; antiphospholipid antibodies and lupus anticoagulant negativeactiveconfirmed M32.19S — Synthetic modern diagnosis and results; her systemic lupus erythematosus, diagnosed in Atlanta in late 1950 or early 1951, is documented (D), but no finding from her lifetime is used.
Lupus nephritis, ISN/RPS class III (A), focal proliferative, on kidney biopsy: endocapillary proliferation in 9 of 30 glomeruli, activity index 6 of 24, chronicity index 1 of 12, full-house immunofluorescence; no thrombotic microangiopathy; urine protein-to-creatinine ratio 1.8 g/g; normal kidney functionactiveconfirmed M32.14S — Synthetic biopsy result and class; kidney involvement is documented at the end of her life, but no kidney finding from her lifetime is used.
Long-term glucocorticoid treatment for lupus nephritis, tapering to 5 mg a day or lessactiveconfirmed Z79.52S — Synthetic treatment status; the documented steroid harm in her life is the reason the episode keeps glucocorticoids low.
Long-term mycophenolate mofetil, with belimumab, for lupus nephritis; bone and infection protection in placeactiveconfirmed Z79.624S — Synthetic treatment status.
Levonorgestrel intrauterine system for highly effective contraception during mycophenolate treatmentactiveconfirmed Z97.5S — Synthetic contraception, chosen by the patient.
Acute cystitis on mycophenolate, belimumab, and prednisone 15 mg: two days of burning, frequency, and urgency without fever or flank pain; urine culture grew Escherichia coli sensitive to nitrofurantoin; resolved with seven days of nitrofurantoinresolvedconfirmed N30.00S — Synthetic common infection in an immunosuppressed young woman; coded without hematuria because the persistent hematuria is from her nephritis.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, 1950-1951Completed todayInactivated vaccine given today; live vaccines are avoided on immunosuppression
COVID-19 vaccine, 1950-1951DueRecommended; booked at her pharmacy next week
Pneumococcal vaccineUp to datePCV20 in April, recommended for immunocompromised adults; no further doses
Recombinant zoster vaccineUp to dateTwo doses, in April and July, recommended from 19 for immunocompromised adults
HPV vaccineUp to dateSeries completed in adolescence
Hepatitis B vaccineUp to dateVaccinated in infancy; surface antibody positive and surface antigen negative in April
Tetanus boosterUp to dateTdap seven years ago
Cervical cancer screeningOrderedCytology with HPV testing today, yearly while immunosuppressed
Hepatitis C and HIV screeningUp to dateNegative in April, before immunosuppression
Chlamydia and gonorrhea screeningNot indicatedAge 25 with one long-term partner; offered if risk changes
ContraceptionUp to dateLevonorgestrel intrauterine system since April; required while on mycophenolate
Folic acidCompleted todayAdvised 0.4 mg daily, as for all who could become pregnant
Blood pressure screeningCompleted today116/74 mmHg on losartan
Cholesterol and diabetesUp to dateLDL 128 mg/dL and HbA1c 5.3 percent in July on prednisone; no statin; recheck at one year on a low dose
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C 1, negative
Skin cancer prevention and sun protectionCompleted todayDaily broad-spectrum sunscreen and a hat, also for lupus photosensitivity
Physical activity and diet counselingCompleted todayWalking most days; calcium-rich foods; low salt for blood pressure and the kidneys

Immunizations given today: Influenza vaccine, 1950-1951 season [S]

Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Cervical screening result by portal message. Six-month lupus nephritis assessment this month. COVID-19 vaccine next week. Next scheduled visit 1950-10-26: six-month response assessment: complete renal response; prednisone 5 mg; pregnancy planning. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 15 minutes, with her consent. She has named a close friend as her health care agent and completed a written health care directive today, now scanned into the chart. Her first instruction is that she is to be told the truth about her illness directly, and that no clinician is to give her information to anyone else before giving it to her. She would want full treatment for a lupus flare or an infection; she would not want prolonged life support if she could not expect to recover the ability to read and write. [S]